Beutel Goodman & Co Ltd. lowered its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 0.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,984,681 shares of the technology company's stock after selling 6,391 shares during the period. Amdocs accounts for 2.3% of Beutel Goodman & Co Ltd.'s investment portfolio, making the stock its 8th biggest holding. Beutel Goodman & Co Ltd. owned approximately 4.42% of Amdocs worth $424,395,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also bought and sold shares of the company. Orion Portfolio Solutions LLC raised its stake in Amdocs by 9.8% in the 4th quarter. Orion Portfolio Solutions LLC now owns 50,519 shares of the technology company's stock valued at $4,301,000 after acquiring an additional 4,506 shares during the period. Norges Bank bought a new stake in shares of Amdocs in the fourth quarter valued at approximately $824,000. Signature Estate & Investment Advisors LLC lifted its stake in shares of Amdocs by 5.2% during the 4th quarter. Signature Estate & Investment Advisors LLC now owns 24,623 shares of the technology company's stock valued at $2,096,000 after buying an additional 1,212 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Amdocs by 16.1% in the 4th quarter. Vanguard Group Inc. now owns 3,074,424 shares of the technology company's stock worth $261,756,000 after buying an additional 426,035 shares during the period. Finally, LPL Financial LLC grew its stake in Amdocs by 25.4% in the 4th quarter. LPL Financial LLC now owns 123,015 shares of the technology company's stock valued at $10,473,000 after buying an additional 24,947 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.
Analysts Set New Price Targets
Separately, StockNews.com downgraded Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Amdocs currently has a consensus rating of "Moderate Buy" and an average target price of $101.20.
Check Out Our Latest Stock Analysis on Amdocs
Amdocs Price Performance
Amdocs stock traded up $0.11 during midday trading on Wednesday, reaching $91.12. 151,904 shares of the stock were exchanged, compared to its average volume of 685,945. Amdocs Limited has a 52 week low of $74.41 and a 52 week high of $93.34. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16. The firm has a market cap of $10.29 billion, a PE ratio of 21.14, a PEG ratio of 1.47 and a beta of 0.68. The company's fifty day moving average is $88.13 and its 200-day moving average is $87.43.
Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. On average, sell-side analysts forecast that Amdocs Limited will post 6.21 EPS for the current year.
Amdocs Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Monday, March 31st will be issued a dividend of $0.527 per share. This is a positive change from Amdocs's previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.11 annualized dividend and a dividend yield of 2.31%. Amdocs's payout ratio is presently 48.72%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
